By Laurie Fullerton

Talk about the power of the pen! Social media rebelled against the British pharmaceutical company Mylan this week – producers of the poplular EpiPen – and the company’s poor reaction, particularly under the harsh scrutiny of social media and its strong stance – saw its stock plummet to an all time low.

Following the backlash, the company just announced that the maker of EpiPens will start selling a cheaper, generic version of the emergency allergy shots in an article that appeared in the L.A. Times today. However, the furor over repeated U.S. price hikes continues — and Read full story ›

Source: The Drum